RecruitingACTRN12605000037606

NIVOAD Study: Non Invasive Ventilation in Obstructive Airways Diseases Study

NIVOAD Study: Non Invasive Ventilation duration in Obstructive Airways Diseases Study


Sponsor

Dr Anthony Cross

Enrollment

192 participants

Start Date

Jun 1, 2005

Study Type

Interventional

Conditions


Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Plain Language Summary

Simplified for easier understanding

This study compares two types of breathing support masks (non-invasive ventilation, or NIV) used in the emergency department for people having a moderate to severe asthma or COPD attack. Both masks help push air into the lungs without needing a breathing tube. The study aims to find out which approach works best. You may be eligible if: - You are 18 years of age or older - You are being treated in an emergency department for a moderate to severe flare-up of asthma or COPD (chronic obstructive pulmonary disease) - Your breathing is laboured (rapid breathing, low oxygen levels, or difficulty speaking in full sentences) - Your doctor has decided that non-invasive ventilation is needed You may NOT be eligible if: - You are too drowsy or confused to cooperate or protect your own airway - Your breathing failure is caused by something other than asthma or COPD - You have an untreated collapsed lung (pneumothorax) - You need a breathing tube placed in your throat - Your medical team has decided to withhold or withdraw treatment Talk to your doctor about whether this trial might be right for you.

This is a simplified summary. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

CPAP vs BiPAP The duration is unknown but it is estimated to be in the order of 120 minutes

CPAP vs BiPAP The duration is unknown but it is estimated to be in the order of 120 minutes


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12605000037606


Related Trials